News
Bozeman Takeda branch involved with push for Zika vaccine
September 3, 2016 /
Takeda announced Thursday it had received $19.8 million from the U.S. Department of Health and Human Services to develop the vaccine, with a first phase of clinical trials set for 2017.
It also says it could receive as much as $312 million in public funding if the research moves through multiple phases of trials.
By Eric Dietrich Chronicle Staff Writer
MATR Supporters (view all)
Posted in: Biotech
Sorry, we couldn't find any posts. Please try a different search.